Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines, LCL-209 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ET-01 in subjects with lateral canthal lines (crow's feet) has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crow Feet
• Lateral Canthal Lines

Drugs mentioned

• ET-01

Snippet

Sponsor: Eirion Therapeutics Inc. | Conditions: Lateral Canthal Lines, LCL, Crow's Feet | Phase 2 | Status: COMPLETED | Results posted: 2022-06-24